SCHEMBL2427157

SCHEMBL2427157

CC(C)(C)OC(=O)NC1CCC(Nc2cc(C(=O)OCc3ccccc3)ccc2C#N)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNA3 P22001 1/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ KMT2A Q03164 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ RORC P51449 2/20 0.42
▸ TSHR P16473 1/20 0.41
▸ KDM1A O60341 1/20 0.41
▸ MAOB P27338 1/20 0.41
▸ FAAH O00519 1/20 0.41
▸ EPHX2 P34913 1/20 0.41
▸ CTSL P07711 1/20 0.41
▸ CTSB P07858 1/20 0.41
▸ CTSK P43235 1/20 0.41
▸ DRD2 P14416 2/20 0.41
▸ NSD2 O96028 1/20 0.40
▸ CA1 P00915 2/20 0.40
▸ CA2 P00918 2/20 0.40
▸ ACHE P22303 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2427152 1.00 KCNA3 (0.43) KCNA3ALOX15ALDH1A1GAAKMT2A
SCHEMBL2426985 0.88 ALOX15 (0.47) KCNA3ALOX15KDM1AMAOBEPHX2
SCHEMBL2426983 0.88 ALOX15 (0.47) KCNA3ALOX15KDM1AMAOBEPHX2
SCHEMBL2428992 0.85 DRD2 (0.44) KCNA3ALDH1A1KMT2AL3MBTL1KDM1A
SCHEMBL2428995 0.85 DRD2 (0.44) KCNA3ALDH1A1KMT2AL3MBTL1KDM1A
SCHEMBL2432136 0.84 ALOX15 (0.57) ALOX15ALDH1A1KMT2APRKCQ
SCHEMBL12820827 0.78 AAK1 (0.45) KCNA3KDM1AMAOBCTSKDRD2
SCHEMBL851577 0.77 ST14 (0.44) KCNA3RORCFAAHEPHX2DRD2
SCHEMBL6153463 0.77 ALDH1A1 (0.69) ALDH1A1GAAKMT2AL3MBTL1TSHR
SCHEMBL3944464 0.77 ALDH1A1 (0.69) ALDH1A1GAAKMT2AL3MBTL1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8012956-B2 Tropane compounds EXELIXIS, INC. (US) 2011-09-06 — — US disclosed
EP-2074120-B1 TROPANE COMPOUNDS EXELIXIS INC (US) 2010-03-03 — — EP disclosed
EP-2074120-A1 TROPANE COMPOUNDS Exelixis, Inc. (US) 2009-07-01 — — EP disclosed
US-20090163471-A1 Tropane compounds EXELIXIS, INC. 2009-06-25 — — US disclosed
WO-2009055077-A1 TROPANE COMPOUNDS EXELIXIS, INC. (US) 2009-04-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163471-A1 Tropane compounds ADRA1B, ADRA2B, ADRB2 KCNA3 2462/4885ALOX15 1532/4885ALDH1A1 323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback